Highlighting the importance of chronic inflammation in the atherosclerotic process, studies have increasingly demonstrated the link between high levels of pro-inflammatory cytokines, such as IL-6, TNF-α, and IL-1β, and progression and instability of atherosclerosis plaque, pointing out their potential as novel target therapy [30,41,42,43]. Here, IL1B is linked to atherosclerosis.